Trexquant Investment’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.77M | Sell |
15,171
-30,882
| -67% | -$14.4M | 0.05% | 530 |
|
|
2025
Q4 | $20.9M | Buy |
46,053
+40,637
| +750% | +$17.5M | 0.19% | 105 |
|
|
2025
Q3 | $2.12M | Buy |
+5,416
| New | +$2.26M | 0.02% | 886 |
|
|
2024
Q2 | – | Sell |
-5,904
| Closed | -$2.47M | – | 1874 |
|
|
2024
Q1 | $2.47M | Buy |
5,904
+1,936
| +49% | +$818K | 0.05% | 574 |
|
|
2023
Q4 | $1.61M | Buy |
3,968
+2,449
| +161% | +$905K | 0.04% | 632 |
|
|
2023
Q3 | $528K | Buy |
+1,519
| New | +$531K | 0.01% | 990 |
|
|
2023
Q2 | – | Sell |
-4,176
| Closed | -$1.32M | – | 1839 |
|
|
2023
Q1 | $1.32M | Sell |
4,176
-48,044
| -92% | -$14.4M | 0.04% | 620 |
|
|
2022
Q4 | $15.1M | Buy |
52,220
+23,040
| +79% | +$7.02M | 0.43% | 34 |
|
|
2022
Q3 | $8.45M | Buy |
+29,180
| New | +$8.4M | 0.3% | 76 |
|
|
2021
Q4 | – | Sell |
-15,061
| Closed | -$2.73M | – | 1651 |
|
|
2021
Q3 | $2.73M | Buy |
+15,061
| New | +$2.94M | 0.22% | 121 |
|
|
2020
Q4 | – | Sell |
-18,712
| Closed | -$5.09M | – | 1526 |
|
|
2020
Q3 | $5.09M | Buy |
18,712
+8,206
| +78% | +$2.26M | 0.33% | 62 |
|
|
2020
Q2 | $3.05M | Sell |
10,506
-3,851
| -27% | -$1.04M | 0.21% | 125 |
|
|
2020
Q1 | $3.42M | Sell |
14,357
-13,134
| -48% | -$3.01M | 0.25% | 97 |
|
|
2019
Q4 | $6.02M | Buy |
27,491
+9,262
| +51% | +$1.87M | 0.36% | 73 |
|
|
2019
Q3 | $3.09M | Buy |
18,229
+9,027
| +98% | +$1.6M | 0.27% | 112 |
|
|
2019
Q2 | $1.69M | Sell |
9,202
-14,745
| -62% | -$2.58M | 0.15% | 199 |
|
|
2019
Q1 | $4.41M | Buy |
+23,947
| New | +$4.42M | 0.31% | 78 |
|
|
2018
Q4 | – | Sell |
-6,646
| Closed | -$1.28M | – | 1330 |
|
|
2018
Q3 | $1.28M | Sell |
6,646
-22,733
| -77% | -$4.05M | 0.1% | 290 |
|
|
2018
Q2 | $4.99M | Buy |
29,379
+5,101
| +21% | +$791K | 0.35% | 70 |
|
|
2018
Q1 | $3.96M | Buy |
+24,278
| New | +$3.97M | 0.28% | 82 |
|
|
2017
Q4 | – | Sell |
-5,664
| Closed | -$861K | – | 1276 |
|
|
2017
Q3 | $861K | Buy |
5,664
+3,354
| +145% | +$505K | 0.22% | 110 |
|
|
2017
Q2 | $298K | Sell |
2,310
-14,290
| -86% | -$1.72M | 0.08% | 474 |
|
|
2017
Q1 | $1.81M | Buy |
16,600
+13,100
| +374% | +$1.15M | 0.23% | 74 |
|
|
2016
Q4 | $258K | Buy |
+3,500
| New | +$285K | 0.04% | 711 |
|
|
2016
Q2 | – | Sell |
-11,500
| Closed | -$914K | – | 1129 |
|
|
2016
Q1 | $914K | Sell |
11,500
-6,300
| -35% | -$570K | 0.11% | 323 |
|
|
2015
Q4 | $2.24M | Buy |
+17,800
| New | +$2.15M | 0.2% | 131 |
|
|
2015
Q3 | – | Sell |
-20,000
| Closed | -$2.47M | – | 1277 |
|
|
2015
Q2 | $2.47M | Buy |
20,000
+14,000
| +233% | +$1.76M | 0.28% | 41 |
|
|
2015
Q1 | $707K | Buy |
+6,000
| New | +$719K | 0.07% | 538 |
|
Other funds holding VRTX
VCM
VPM
Trexquant Investment's VRTX Position: Q1 2026 in Review
Trexquant Investment reduced its Vertex Pharmaceuticals (VRTX) stake by 67% in Q1 2026, selling an estimated $14.4M and leaving 15,171 shares worth $6.77M. The position accounts for 0.05% of the portfolio, ranked #530.
Trexquant Investment first reported a position in VRTX in Q1 2015 and has held it in 28 quarters since. The position peaked at $20.9M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Trexquant Investment held 15,171 shares of Vertex Pharmaceuticals worth $6.77M as of Q1 2026.
- Trexquant Investment sold 30,882 Vertex Pharmaceuticals shares in Q1 2026, an estimated $14.4M.
- Vertex Pharmaceuticals made up 0.05% of Trexquant Investment's portfolio in Q1 2026, its #530 holding.
- Trexquant Investment first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 28 quarters since.
- Trexquant Investment's Vertex Pharmaceuticals position peaked at $20.9M in Q4 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.